These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24066305)

  • 1. RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.
    Benter IF; Babiker F; Al-Rashdan I; Yousif M; Akhtar S
    J Diabetes Res; 2013; 2013():427693. PubMed ID: 24066305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
    Parlakpinar H; Ozer MK; Acet A
    Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-I and ischemia on functional recovery in isolated hearts.
    Oliveira UO; Oliveira AR; Kucharski LC; Machado UF; Irigoyen MC; Schaan BD
    Arq Bras Cardiol; 2011 Nov; 97(5):390-6. PubMed ID: 21971632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
    Ozer MK; Sahna E; Birincioglu M; Acet A
    Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution.
    Hoyer A; Kempfert J; Pritzwald-Stegmann P; Mohr FW; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1221-9. PubMed ID: 25308324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
    Takeda H; Haneda T; Kikuchi K
    Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.
    Azevedo ER; Mak S; Floras JS; Parker JD
    Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R410-R417. PubMed ID: 28679681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
    Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptors.
    Sgarra L; Leo V; Addabbo F; Iacobazzi D; Carratù MR; Montagnani M; Potenza MA
    PLoS One; 2014; 9(2):e88542. PubMed ID: 24520397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
    Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
    Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
    Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
    J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist on metabolism and contraction in ischemia-reperfused rabbit heart.
    Kawabata H; Ryomoto T; Ishikawa K
    Jpn Circ J; 2000 Apr; 64(4):276-82. PubMed ID: 10783050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats.
    Ozhan O; Parlakpinar H; Acet A
    Fundam Clin Pharmacol; 2021 Aug; 35(4):669-680. PubMed ID: 32810901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
    Yoshiyama M; Kim S; Yamagishi H; Omura T; Tani T; Yanagi S; Toda I; Teragaki M; Akioka K; Takeuchi K
    Am Heart J; 1994 Jul; 128(1):1-6. PubMed ID: 8017262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L; Duce B; Miric G; Sernia C
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.